Another study using NLRP3-deficient mice or the NLRP3 inhibitor INF-39 found suppression of the maturation and release of IL1β and further prevention of the inflammatory cascade in a cerulein plus LPS-induced AP model [34]. This evidence concerns the gene IL1B and alkaline phosphatase measurement.